Series date: 
01/01/2024 - 7:30am to 12/31/2024 - 8:30am

COURSE DIRECTOR
Ladan Zand, MD and Iasmina Craici, MD

DESCRIPTION
Each week, a fellow selects an article from a relevant journal to discuss.  The expectation is to ask a consultant to review the article choice and assist in the discussion of the article.  One week prior to the conference, the journal article is electronically distributed to division members.  

TARGET AUDIENCE
The audience is primarily the physicians in our division, but all members of the division, i.e. nurses, NP/PAs and allied health staff are encouraged to attend.  Other areas/divisions are allowed to attend if they wish.  

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Identify how to apply clinical practice updates to improve patient outcomes.
  • Review clinical and basic research literature using an evidence-based approach.
  • Debate if specific findings are relevant and applicable to patient care.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:

Hatem Amer, M.D. - Grant/Research - Kaneka Pharma 

Ladan Zand, MD - Consultant - Travere Therapeutics, Inc.; Calliditas NA Enterprises, Inc.

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies: 
Iasmina Craici, MD; Diane Chicos, Melissa Hanson, Kathleen Hegna Zelinske, and Jacqlyn Oakland

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Kathy Hegna Zelinske at phone 6-1044 OR Jacqlyn Oakland at phone 4-3479

*Required Information for Accreditation is posted in Outlook Calendar Invitation.

Where did the idea for the course originate?: 
Minnesota

Sessions

Session Date
Nephrology Hypertension Journal Club Role of light chain clearance in the recovery of renal function in multiple myeloma: another point of view July 12 2024 07/12/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Dialysate Sodium Lowering in Maintenance Hemodialysis July 19 2024 07/19/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Adherence to Plant Based Diets and Risk of CKD Progression and All Cause Mortality Findings From the Chronic Renal Insufficiency Cohort CRIC Study July 26 2024 07/26/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club A Randomized Trial of Intravenous Amino Acids for Kidney Protection August 2nd 2024 08/02/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients with Type 2 Diabetes August 16th 2024 08/16/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Preventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease August 23 2024 08/23/2024 - 7:30am to 8:30am
CANCELLED Nephrology Hypertension Journal Club Sodium F18-FDG PET Imaging as a diagnostic tool for immune checkpoint inhibitor associated acute kidney injury August 30 2024 08/30/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club Autoantibodies Targeting Nephrin in Podocystopathies September 13 2024 09/13/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes September 20, 2024 09/20/2024 - 7:30am to 8:30am
Nephrology Hypertension Journal Club: A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection 09/27/2024 - 7:30am to 8:30am

Pages